MacroGenics, Inc.
MGNX
$4.11
-$0.21-4.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 32.83M | 6.72M | 41.23M | 72.84M | 6.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.83M | 6.72M | 41.23M | 72.84M | 6.87M |
| Cost of Revenue | 38.78M | 34.97M | 44.09M | 44.30M | 40.79M |
| Gross Profit | -5.95M | -28.25M | -2.86M | 28.54M | -33.92M |
| SG&A Expenses | 7.90M | 9.71M | 9.24M | 9.91M | 9.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.68M | 44.68M | 53.32M | 54.20M | 50.09M |
| Operating Income | -13.85M | -37.96M | -12.10M | 18.64M | -43.22M |
| Income Before Tax | -69.64M | -41.30M | -14.93M | 16.82M | -42.61M |
| Income Tax Expenses | -- | -- | -777.00K | -- | 105.00K |
| Earnings from Continuing Operations | -69.64M | -41.30M | -14.16M | 16.82M | -42.72M |
| Earnings from Discontinued Operations | 89.16M | 4.52M | -- | -- | 6.47M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.52M | -36.77M | -14.16M | 16.82M | -36.25M |
| EBIT | -13.85M | -37.96M | -12.10M | 18.64M | -43.22M |
| EBITDA | -13.14M | -36.28M | -10.39M | 20.43M | -41.32M |
| EPS Basic | 0.31 | -0.58 | -0.22 | 0.27 | -0.57 |
| Normalized Basic EPS | -0.17 | -0.41 | -0.15 | 0.17 | -0.42 |
| EPS Diluted | 0.30 | -0.58 | -0.22 | 0.27 | -0.57 |
| Normalized Diluted EPS | -0.17 | -0.41 | -0.15 | 0.17 | -0.42 |
| Average Basic Shares Outstanding | 63.59M | 63.45M | 63.28M | 63.23M | 63.14M |
| Average Diluted Shares Outstanding | 63.59M | 63.45M | 63.28M | 63.28M | 63.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |